GET DAILY SIGNALSIDEV vs IXUS: Weighing Developed Markets Against Broader International Exposure
Key Takeaways
- Both funds are low-cost international equity ETFs from iShares, but IDEV covers developed markets only, while IXUS adds emerging-market exposure across roughly 4,300 holdings.
- IDEV carries the lower expense ratio (0.04%) and skews toward financials, industrials, and healthcare; IXUS charges 0.07% but holds heavier weight in AI-driven semiconductor leaders such as Taiwan Semiconductor and Samsung.
- Recent relative performance favors IXUS, whose technology and emerging-market tilt has provided stronger near-term momentum and broader geographic diversification.
- Tickeron AI Verdict: Based on trend consistency, catalyst exposure, and relative positioning, Tickeron's AI would currently lean toward IXUS over IDEV.
- Explore IDEV Major News and IDEV Today's Price Move, plus IXUS Major News and IXUS Today's Price Move, for deeper, up-to-date coverage of each fund.
- For additional market signals, explore Trending AI Robots.
Why These Two ETFs Stand Out
Investors seeking diversified exposure to non-U.S. equities often weigh two closely related iShares exchange-traded funds (ETFs): the iShares Core MSCI International Developed Markets ETF (IDEV) and the iShares Core MSCI Total International Stock ETF (IXUS). Both are market-capitalization-weighted index funds designed to capture international stock performance, yet they diverge in one key respect: IDEV excludes emerging markets, while IXUS includes them. This distinction shapes each fund's sector mix, growth drivers, and risk profile. This comparison is most relevant for long-term investors and traders evaluating how much emerging-market and technology exposure to hold within a global equity allocation. I also checked this using Tickeron’s AI Screener to see how the funds line up against peers.
IDEV Overview and Recent Performance
The iShares Core MSCI International Developed Markets ETF (IDEV) tracks the MSCI World ex USA Investable Market Index, providing access to large-, mid-, and small-cap companies across developed markets in Europe, Asia-Pacific, and Canada. With an expense ratio of just 0.04% and more than 2,300 holdings, it is among the lowest-cost ways to own developed international equities.
In recent market activity, IDEV has benefited from strength in Japanese and European financials, where higher interest rates have supported bank lending margins, as well as resilient performance from healthcare and industrial names. Top holdings include ASML, HSBC, Roche, Royal Bank of Canada, and Nestlé. Over the trailing twelve months, the fund has posted solidly positive returns, though its developed-market focus means it has captured less of the AI-driven semiconductor rally than broader international benchmarks. Sentiment has been steady, supported by its low cost and lower sensitivity to emerging-market volatility.
IXUS Overview and Recent Performance
The iShares Core MSCI Total International Stock ETF (IXUS) tracks the MSCI ACWI ex USA Investable Market Index, combining developed and emerging markets in a single vehicle with roughly 4,300 holdings and a 0.07% expense ratio. Its top country exposures include Japan, Taiwan, the United Kingdom, Canada, and China.
Recent performance has been driven by outsized gains in Asian technology, particularly Taiwan Semiconductor Manufacturing, Samsung Electronics, and SK Hynix, which have surged alongside global demand for advanced chips tied to artificial intelligence. This exposure has helped IXUS deliver strong year-to-date and trailing one-year returns, at times outpacing U.S. benchmarks. Broader emerging-market recovery and a softer U.S. dollar have added further support. The trade-off is modestly higher cost and added sensitivity to emerging-market political and currency risks. When reviewing sector weights, Tickeron’s AI Trend Prediction Engine highlighted the semiconductor tilt as a key differentiator.
Head-to-Head Comparison
The core contrast between IDEV and IXUS is scope. IDEV is the purer "developed world" play, with a heavier tilt toward financials, industrials, and healthcare, and a lower fee. IXUS layers in emerging markets, adding meaningful weight to information technology and consumer names across Asia.
In terms of growth drivers, IXUS is more levered to the global AI and semiconductor cycle, a key catalyst behind recent outperformance. IDEV relies more on developed-market financials and healthcare, which offer steadier, less volatile contributions. On risk, IDEV generally exhibits lower volatility and fewer emerging-market political and currency risks, while IXUS offers broader diversification but with added sensitivity to China and other developing economies. Market sentiment has favored IXUS recently, reflecting enthusiasm for AI-linked technology and rebounding emerging markets.
Where the Analysis Points
Based on observable factors such as trend consistency, catalyst exposure, and relative positioning, Tickeron's AI would likely favor IXUS in the current environment. The fund's heavier allocation to AI-driven semiconductor leaders and emerging markets has translated into stronger recent momentum and broader growth catalysts. IDEV remains an attractive, lower-cost option for investors prioritizing stability and developed-market exposure, but its narrower scope has trailed in relative performance terms. This assessment is probabilistic rather than definitive and reflects current market conditions rather than a forecast of future results.
Adding Data-Driven Perspective with AI Tools
In my research process, I regularly review Tickeron’s Trending AI Robots to see how automated strategies align with broader market signals. The page highlights bots with notable track records across different styles and timeframes, which can offer a useful complement when evaluating holdings like these two ETFs. It helps filter through the noise without replacing fundamental analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
IXUS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for IXUS turned positive on October 28, 2026. Looking at past instances where IXUS's MACD turned positive, the stock continued to rise in 42 of 45 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +1.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXUS advanced for three days, in 285 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 59 cases where IXUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IXUS as a result. In 65 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
IXUS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IXUS crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for IXUS entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ForeignLargeBlend
Advertisement